The Effect of an Oxytocin Decision Support Checklist on Oxytocin Use and Maternal and Neonatal Outcomes: A Retrospective Cohort Study
American Journal of Perinatology · 01.10.2024 · 41 (14) · 1936-1947
DOI: 10.1055/a-2278-9119 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift American Journal of Perinatology, erschienen am 01.10.2024. Verfasst von Nazineen Kandahari und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, School of Medicine, University of California, San Francisco, California. Hauptthemen laut MEDLINE: Oxytocin, Checklist, Oxytocics. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Kaiser Permanente.
Abstract (Originalsprache)
Objective
To assess the association between use of an oxytocin decision support checklist with oxytocin usage and clinical outcomes. Study Design We conducted a retrospective cohort study of patients with singleton gestations at 370/7 weeks or greater who received oxytocin during labor from October 2012 to February 2017 at an integrated community health care system during three exposure periods: (1) prechecklist; (2) after paper checklist implementation; and (3) after checklist integration into the electronic medical record (EMR). The checklist was a clinical decision support tool to standardize the dosing and management of oxytocin. Thus, our primary outcomes included oxytocin infusion rates and cumulative dose. Secondary outcomes included maternal and neonatal outcomes. We controlled for maternal risk factors with multivariable regression analysis and stratified by mode of delivery.
Results
A total of 34,269 deliveries were included. Unadjusted analyses showed that compared with prechecklist, deliveries during the paper and EMR-integrated periods had a lower cumulative dose (4,670 ± 6,174 vs. 4,318 ± 5,719 and 4,286 ± 5,579 mU, p < 0.001 for both), lower maximal infusion rate (9.9 ± 6.8 vs. 8.7 ± 5.8 and 8.4 ± 5.6 mU/min, p < 0.001 for both), and longer duration of oxytocin use (576 ± 442 vs. 609 ± 476 and 627 ± 488 minutes, p < 0.001 and p = 0.01, respectively). The unadjusted rates of cesarean, 5-minute Apgar
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, School of Medicine, University of California, San Francisco, California.
- Division of Research, Kaiser Permanente Northern California, Oakland, California.
- Department of Obstetrics and Gynecology, The Permanente Medical Group, Oakland, California.
- Department of Obstetrics and Gynecology, INOVA Medical Group-Cares, Falls Church, Virginia.
- Department of Maternal Fetal Medicine, The Permanente Medical Group, Kaiser Permanente Northern California, Walnut Creek, California.
Förderung
- Kaiser Permanente
Zitieren
APA
Kandahari, N., Tucker, L. Y., Raine-Bennett, T., Palacios, J., Schneider, A. N., & Mohta, V. J. (2024). The Effect of an Oxytocin Decision Support Checklist on Oxytocin Use and Maternal and Neonatal Outcomes: A Retrospective Cohort Study. American Journal of Perinatology, 41(14), 1936-1947. https://doi.org/10.1055/a-2278-9119
Vancouver
Kandahari N, Tucker LY, Raine-Bennett T, Palacios J, Schneider AN, Mohta VJ. The Effect of an Oxytocin Decision Support Checklist on Oxytocin Use and Maternal and Neonatal Outcomes: A Retrospective Cohort Study. American Journal of Perinatology. 2024;41(14):1936-1947. doi:10.1055/a-2278-9119
BibTeX
@article{Kandahari2024,
author = {Kandahari, Nazineen and Tucker, Lue-Yen and Raine-Bennett, Tina and Palacios, Janelle and Schneider, Allison N and Mohta, Vanitha J},
title = {The Effect of an Oxytocin Decision Support Checklist on Oxytocin Use and Maternal and Neonatal Outcomes: A Retrospective Cohort Study},
journal = {American Journal of Perinatology},
year = {2024},
volume = {41},
number = {14},
pages = {1936--1947},
doi = {10.1055/a-2278-9119}
}
EUVIMED